Bladder Diary for Diagnosing Bladder Oversensitivity
NCT04981015 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3960
Last updated 2021-07-28
Summary
Urodynamic study is an invasive procedure and applied for diagnosis of bladder oversensitivity. Bladder diary is a non-invasive measurement. The aim of this study was to elucidate whether bladder diary is a good surrogate for diagnosing bladder oversensitivity.
Conditions
- Bladder Oversensitivity
Interventions
- DIAGNOSTIC_TEST
-
Three-day bladder diary
A three-day bladder diary for recording voiding-flow pattern of a women
Sponsors & Collaborators
-
National Taiwan University Hospital
lead OTHER
Principal Investigators
-
Ho-Hsiung Lin, PhD · National Taiwan University Hospital
Eligibility
- Min Age
- 20 Years
- Max Age
- 85 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-07-01
- Primary Completion
- 2020-12-31
- Completion
- 2020-12-31
Countries
- Taiwan
Study Locations
More Related Trials
-
Therapeutic Efficacy and Safety of Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
NCT03044912 ·Status: UNKNOWN ·Phase: PHASE3
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN
-
Urinary Neurotrophin Levels as Potential Biomarkers for Overactive Bladder: A Case-Control Study
NCT06563193 ·Status: ENROLLING_BY_INVITATION
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED
-
Mirabegron for Female OAB Patients: Comparison of Daytime and Nighttime Dosing
NCT03251300 ·Status: UNKNOWN ·Phase: PHASE4
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Studies of Psychiatric Predisposing Factors, Treatment-related Cardiovascular Effects, and Prognostic Factors Associated With Antimuscarinic Drug (Tolterodine) for Female Overactive Bladder Syndrome
NCT01503580 ·Status: COMPLETED ·Phase: NA
-
Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug
NCT01627145 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms
NCT04999657 ·Status: COMPLETED ·Phase: NA
-
Risk Factors for Treatment Failure in Women With Detrusor Overactivity Receiving Combined Pharmacotherapy
NCT07337252 ·Status: COMPLETED
-
Pharmacologic Effect for Female Overactive Bladder Syndrome: Mirabegron Versus Solifenacin
NCT04023253 ·Status: UNKNOWN ·Phase: PHASE3
-
Comparing Treatments for Overactive Bladder in Taiwan: A Study of Outcomes
NCT07025642 ·Status: RECRUITING ·Phase: NA
-
Herbal Patch for Overactive Bladder
NCT03532789 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Desmopressin for Improving Nocturnal Enuresis in Patients After Radical Cystectomy With Bladder Reconstruction
NCT01582542 ·Status: UNKNOWN ·Phase: PHASE4
-
Validation of a Real-time Urodynamic Measure of Urinary Urgency
NCT00909428 ·Status: COMPLETED ·Phase: PHASE4
-
Mirabegron Treatment on Patients With Overactive Bladder Syndrome in Taiwan
NCT03059134 ·Status: COMPLETED ·Phase: PHASE3
-
"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver
NCT01408771 ·Status: COMPLETED
-
Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.
NCT00481728 ·Status: COMPLETED ·Phase: PHASE1
-
Desmopressin Melt Therapy in Patients With Nocturnal Polyuria: a Pharmacokinetic/Dynamic Study
NCT01435083 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome
NCT03695822 ·Status: WITHDRAWN ·Phase: PHASE4
-
Overactive Bladder Syndrome
NCT05151081 ·Status: COMPLETED
-
Uroflowmetry and Nocturnal Enuresis
NCT07028645 ·Status: ACTIVE_NOT_RECRUITING
-
Comparisons of the Impact of Duloxetine Versus Imipramine on Therapeutic Efficacy, Psychological Distress, Sexual Function, Urethral and Bladder Wall Structure and Blood Flow in Women With Stress Urinary Incontinence: a Randomized Controlled Study
NCT04412876 ·Status: WITHDRAWN ·Phase: PHASE3
-
Experience Sampling Method in OAB Patients
NCT03435991 ·Status: UNKNOWN
-
A Study to Evaluate Safety, Tolerability and Pharmacokinetics of DA-8010 in Healthy Subjects
NCT02821312 ·Status: UNKNOWN ·Phase: PHASE1